Photo by Towfiqu barbhuiya on Unsplash
Nationwide Recall of Robitussin Cough Syrup
January 25, 2024
In a recent announcement, the American subsidiary of the U.K.-based consumer health company, Haleon, issued a nationwide recall of its popularly used Robitussin cough syrup. The recall is a safety measure following the discovery of microbial contamination within the product.
Although it’s a common household item for cold, flu, hay fever, and other respiratory allergies, the recent event demands immediate attention, particularly for those with compromised immune systems. These confounding microbes lurking in the product could potentially result in severe or even life-threatening fungal infections.
While most users are unlikely to suffer serious health consequences, the company has not dismissed the possibility of infections that may necessitate medical intervention. Hence, the precautionary recall.
The recall specifically targets the Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult products. This includes a 4-ounce bottle with the lot number T10810, set to expire on Oct. 31, 2025. The same product, but with an 8-ounce bottle size and lot numbers T08730, T08731, T08732, and T08733, will expire on May 31, 2025. Another 8-ounce batch with the lot number T10808 is expected to expire on Sept. 30, 2025. Lastly, the Robitussin Honey CF Max NT Adult 8-ounce variety under lot numbers T08740 and T08742 is due to expire on June 30, 2026.
If you’ve recently purchased any of the recalled products, Haleon explicitly advises you to refrain from using them to avoid potential health risks. The company remains available for queries related to the recall, providing a toll-free number 800-245-1040 active from Monday to Friday, 8 a.m. to 6 p.m. ET. Alternatively, you may reach out to them via email at mystory.us@haleon.com.
This unexpected recall is a wake-up call for consumers to be vigilant about the products they use and consume, especially those related to health and well-being. Regularly check the news for updates and announcements like this to ensure you are not using any recalled products.
Recent News
Massive Data Breach Hits Ticketmaster, Affecting 560 Million Customers
Ticketmaster has fallen victim to a significant cyber-attack, potentially compromising the data of up to 560 million customers. The breach was confirmed by Ticketmaster’s parent company, Live Nation, which revealed that a notorious hacking group, ShinyHunters, is behind the attack. The hackers are demanding a ransom of approximately £400,000 to prevent the data from being sold on the dark web.
Toyota Recalls 100,000+ Tundra and Lexus LX SUVs Over Engine Debris Issue
Toyota has announced a recall for over 100,000 Tundra pickups and Lexus LX SUVs in North America due to potential engine issues caused by machining debris. This recall affects certain 2022-2023 models of the Tundra and LX, which are equipped with the new V6 twin-turbo engine. The V6 twin-turbo engine has faced considerable scrutiny regarding its reliability, especially when compared to the previous naturally aspirated V8 engines.
Wordle and Worldle Battle Over Names
A legal dispute has erupted between the wildly popular word game Wordle and the lesser-known geography game Worldle, centering on the similarity of their names. Wordle, which was developed by Josh Wardle in 2021 and later acquired by the New York Times in 2022 for a substantial sum, has gained immense popularity. In this game, players have six attempts to guess a five-letter word.
FDA Issues Recall for Crecelac Goat Milk Infant Formula
The U.S. Food and Drug Administration (FDA) has issued a safety alert regarding Crecelac Goat Milk Infant Formula and other infant formula products imported and distributed by Dairy Manufacturers Inc. The alert highlights Cronobacter contamination concerns with Crecelac Infant Powdered Goat Milk Infant Formula. Although Dairy Manufacturers Inc. initiated a recall on May 24, 2024, due to non-compliance with FDA regulations, new findings of Cronobacter contamination have prompted further action.